Rosetta Designed Protein (Toca 511), Now Offering Hope to Brain Cancer Patients

Figure 2.  Pro-drug gene therapy illustration.

Brain cancer is a serious unmet medical challenge, and Washington state is one of the leading research clusters working on glioblastoma.  Here we report on how RosettaDesign proteins are being used to treat brain cancer!  Read more about this important translational protein design effort here.